1 completed, 1 unknown. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Daclatasvir dihydrochloride: new trials by email Literature Review of Daclatasvir dihydrochloride trials Research Report on Daclatasvir dihydrochloride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SH229 Tablets Combined With Daclatasvir Dihydrochloride Tablets in Treatment Adult Patients With Chronic Hepatitis C SH229 tablets, Daclatasvir dihydrochloride - Hepatitis C, Chronic | Phase 2 / Phase 3 | Unknown | Nanjing Sanhome Pharmaceutical, Co., Ltd. | 440 | 2019-03-29 | 2019-08-28 |
| A Drug-drug Interaction Study of SH229 Tablets and Daclatasvir Dihydrochloride Tablets in Healthy Subjects SH229, Daclatasvir dihydrochloride - Drug Interactions | Phase 1 | Completed | Nanjing Sanhome Pharmaceutical, Co., Ltd. | 28 | 2018-11-19 | 2019-08-13 |
Hepatitis C (1) · Hepatitis C, Chronic (1)
Nanjing Sanhome Pharmaceutical, Co., Ltd. (2)
China (2)
Junqi Niu, Ph.D (1) · Yanhua Ding, MD (1)